Under the SPA, NeuroThera will acquire 56,375 CliniQ Shares (the "Purchased Shares"), representing approximately 54.01% of the issued and outstanding ordinary shares of CliniQ from certain ...

Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and ...

SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical ...

IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 March 10, 2026 12:30 PM EDTCompany ParticipantsRichard ...

All right. Well, welcome, everyone. Good morning. Once again, I'm Scott Wurtzel. I cover info services here at Wolfe Research. Excited to be joined by Jonathan Collins, JC, the CFO of Clarivate for a ...

A closer look at the companies driving advancements in laminating roll technology, manufacturing efficiency, and ...

NeuroThera Labs Inc. (TSXV: NTLX) (the "Company" or "NeuroThera"), a clinical-stage biotech company and a majority-owned ...

SALT LAKE CITY, UT / ACCESS Newswire / March 10, 2026 / Path FertilityTM, an epigenetics-driven fertility technology ...

Jill Blumberg of Practical Law asked leading real estate practitioners to share their thoughts on recent developments impacting the US commercial real estate market. Jennifer Chavez Jennifer is a ...

Alpha Modus, Corp. (“Alpha Modus” or the “Company”), a subsidiary of Alpha Modus Holdings, Inc. (“Alpha Modus”) (NASDAQ: AMOD), today announced that it has resolved its patent infringement litigation ...

Virtuix (NASDAQ:VTIX) executives outlined what they described as a “transformative” nine-month period ended December 31, 2025, on the company’s first earnings call as a publicly traded firm.

A peer-reviewed, multi-clinic study published in the Journal of Assisted Reproduction and Genetics suggests an ...